QR kód

In Silico Screening and Testing of FDA-Approved Small Molecules to Block SARS-CoV-2 Entry to the Host Cell by Inhibiting Spike Protein Cleavage

The COVID-19 pandemic began in 2019, but it is still active. The development of an effective vaccine reduced the number of deaths; however, a treatment is still needed. Here, we aimed to inhibit viral entry to the host cell by inhibiting spike (S) protein cleavage by several proteases. We developed...

Celý popis

Uloženo v:
Hlavní autoři: E. Sila Ozdemir, Hillary H. Le, Adem Yildirim, Srivathsan V. Ranganathan
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2022-05-01
Edice:Viruses
Témata:
drug repurposing
SARS-CoV-2
molecular modeling
in silico screening
proteases
On-line přístup:https://www.mdpi.com/1999-4915/14/6/1129
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky